137 related articles for article (PubMed ID: 9797137)
1. Therapeutic efficacy of mouse-human chimeric anti-ganglioside GM2 monoclonal antibody against multiple organ micrometastases of human lung cancer in NK cell-depleted SCID mice.
Hanibuchi M; Yano S; Nishioka Y; Yanagawa H; Kawano T; Sone S
Int J Cancer; 1998 Nov; 78(4):480-5. PubMed ID: 9797137
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient mice.
Sone S; Yano S; Hanibuchi M; Nokihara H; Nishimura N; Miki T; Nishioka Y; Shinohara T
Cancer Chemother Pharmacol; 1999; 43 Suppl():S26-31. PubMed ID: 10357555
[TBL] [Abstract][Full Text] [Related]
3. Immunological circumvention of multiple organ metastases of multidrug resistant human small cell lung cancer cells by mouse-human chimeric anti-ganglioside GM2 antibody KM966.
Hanibuchi M; Yano S; Nishioka Y; Yanagawa H; Miki T; Sone S
Clin Exp Metastasis; 2000; 18(5):353-60. PubMed ID: 11467766
[TBL] [Abstract][Full Text] [Related]
4. Effect of a chimeric anti-ganglioside GM2 antibody on ganglioside GM2-expressing human solid tumors in vivo.
Fukumoto H; Nishio K; Ohta S; Hanai N; Fukuoka K; Ohe Y; Sugihara K; Kodama T; Saijo N
Int J Cancer; 1999 Aug; 82(5):759-64. PubMed ID: 10417777
[TBL] [Abstract][Full Text] [Related]
5. Anti-ganglioside GM2 monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes.
Hanibuchi M; Yano S; Nishioka Y; Yanagawa H; Sone S
Jpn J Cancer Res; 1996 May; 87(5):497-504. PubMed ID: 8641987
[TBL] [Abstract][Full Text] [Related]
6. Combined therapy with anti-P-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in NK cell-depleted SCID mice.
Yano S; Hanibuchi M; Nishioka Y; Nokihara H; Nishimura N; Tsuruo T; Sone S
Int J Cancer; 1999 Jul; 82(1):105-11. PubMed ID: 10360828
[TBL] [Abstract][Full Text] [Related]
7. Genetically engineered humanized anti-ganglioside GM2 antibody against multiple organ metastasis produced by GM2-expressing small-cell lung cancer cells.
Yamada T; Bando H; Takeuchi S; Kita K; Li Q; Wang W; Akinaga S; Nishioka Y; Sone S; Yano S
Cancer Sci; 2011 Dec; 102(12):2157-63. PubMed ID: 21895875
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis induction of human lung cancer cell line in multicellular heterospheroids with humanized antiganglioside GM2 monoclonal antibody.
Nakamura K; Hanibuchi M; Yano S; Tanaka Y; Fujino I; Inoue M; Takezawa T; Shitara K; Sone S; Hanai N
Cancer Res; 1999 Oct; 59(20):5323-30. PubMed ID: 10537316
[TBL] [Abstract][Full Text] [Related]
9. Humanized anti-ganglioside GM2 antibody is effective to induce antibody-dependent cell-mediated cytotoxicity in mononuclear cells from lung cancer patients.
Parajuli P; Yanagawa H; Hanibuchi M; Takeuchi E; Miki T; Yano S; Sone S
Cancer Lett; 2001 Apr; 165(2):179-84. PubMed ID: 11275367
[TBL] [Abstract][Full Text] [Related]
10. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
[TBL] [Abstract][Full Text] [Related]
11. Reversal of adriamycin resistance with chimeric anti-ganglioside GM2 antibody.
Fukumoto H; Nishio K; Ohta S; Hanai N; Saijo N
Int J Cancer; 1996 Sep; 67(5):676-80. PubMed ID: 8782657
[TBL] [Abstract][Full Text] [Related]
12. Novel metastasis model of human lung cancer in SCID mice depleted of NK cells.
Yano S; Nishioka Y; Izumi K; Tsuruo T; Tanaka T; Miyasaka M; Sone S
Int J Cancer; 1996 Jul; 67(2):211-7. PubMed ID: 8760590
[TBL] [Abstract][Full Text] [Related]
13. Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice.
Miki T; Yano S; Hanibuchi M; Sone S
Oncol Res; 2000; 12(5):209-17. PubMed ID: 11417746
[TBL] [Abstract][Full Text] [Related]
14. Monocyte chemoattractant protein-1 gene modification of multidrug-resistant human lung cancer enhances antimetastatic effect of therapy with anti-P-glycoprotein antibody in SCID mice.
Nokihara H; Nishioka Y; Yano S; Mukaida N; Matsushima K; Tsuruo T; Sone S
Int J Cancer; 1999 Mar; 80(5):773-80. PubMed ID: 10048981
[TBL] [Abstract][Full Text] [Related]
15. Human interferon-gamma enhances expression of ganglioside GM2 on human lung cancer cells and their susceptibility for antiganglioside GM2 monoclonal antibody-dependent cellular cytotoxicity.
Hanibuchi M; Nishioka Y; Yanagawa H; Yano S; Parajuli P; Bando M; Sone S
Oncol Res; 2000; 12(4):173-9. PubMed ID: 11341466
[TBL] [Abstract][Full Text] [Related]
16. Reactivity of a mouse/human chimeric anti-GM2 antibody KM966 with brain tumors.
Dohi T; Nakamura K; Hanai N; Taomoto K; Oshima M
Anticancer Res; 1994; 14(6B):2577-81. PubMed ID: 7872684
[TBL] [Abstract][Full Text] [Related]
17. Dissection and optimization of immune effector functions of humanized anti-ganglioside GM2 monoclonal antibody.
Nakamura K; Tanaka Y; Fujino I; Hirayama N; Shitara K; Hanai N
Mol Immunol; 2000 Dec; 37(17):1035-46. PubMed ID: 11399321
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts.
Retter MW; Johnson JC; Peckham DW; Bannink JE; Bangur CS; Dresser K; Cai F; Foy TM; Fanger NA; Fanger GR; Woda B; Rock KL
Cancer Res; 2005 Jul; 65(14):6425-34. PubMed ID: 16024647
[TBL] [Abstract][Full Text] [Related]
19. Recombinant antibodies against ganglioside expressed on tumor cells.
Hanai N; Nakamura K; Shitara K
Cancer Chemother Pharmacol; 2000; 46 Suppl():S13-7. PubMed ID: 10950141
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone-related protein (PTHrP) is responsible for production of bone metastasis, but not visceral metastasis, by human small cell lung cancer SBC-5 cells in natural killer cell-depleted SCID mice.
Miki T; Yano S; Hanibuchi M; Kanematsu T; Muguruma H; Sone S
Int J Cancer; 2004 Feb; 108(4):511-5. PubMed ID: 14696114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
